Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Early retirement planning is essential for achieving financial freedom. Discover the benefits of starting your planning now.
25,214 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
As leveraged ETFs surge in popularity, the active trader dominates turnover in these products, reshaping how markets ...
Palantir stock has fallen from its all-time high, but a fall doesn’t mean a free pass to buy. This guide breaks down ...
Apple’s latest reveal proves the memory-cost squeeze is moving from backdrop to driver, signaling pricing power for m...
June card spending rose 6.3% year over year, with wage gains across all income groups. The latest bofa consumer chief...
In a volatile AI market, SoundHound AI posts a narrower loss for Q4 2025 and lifts 2025 revenue guidance, underscorin...
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
The S&P 500 is posting its fastest earnings growth in nearly five years, led by under-the-radar firms across multiple...
SpaceX’s IPO spectacle invites big questions. History shows that the right move isn’t chasing the initial hype, but b...
Investors are urged to rethink risk in today’s markets: volatility is temporary, but liquidity squeezes and balance-s...
The plant-based meat craze brought BYND into the spotlight, but the path forward is uncertain. This guide examines wh...
Nespresso taps Dua Lipa as its new global ambassador, signaling a deliberate shift from the Clooney era to a Gen Z-fo...